Showing 661-670 of 5688 results for "".

• TRP’n Out: OSD, Inflammation, and Nerves

  https://modernod.com/topics/ocular-surface/trpn-out-osd-inflammation-and-nerves/38581/
  A primer on TRPs and RASP inhibitors.
  • Text

• Promising Safety Results With Investigational Dry Eye Drop

  https://modernod.com/articles/significant-findings/promising-safety-results-with-investigational-dry-eye-drop/37726/
  Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat
  • Text

• Involving Patients in Their Care

  https://modernod.com/articles/significant-findings/involving-patients-in-their-care/37725/
  Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat
  • Text

• PDUFA Date Approaches for Apellis Drug

  https://modernod.com/articles/significant-findings/pdufa-date-approaches-for-apellis-drug/37722/
  Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat
  • Text

• Artificial Tear Brand Linked to Eye Infections

  https://modernod.com/articles/significant-findings/artificial-tear-brand-linked-to-eye-infections/37721/
  Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat
  • Text

• A Renewed Appreciation for Refractions

  https://modernod.com/articles/significant-findings/a-renewed-appreciation-for-refractions/37719/
  Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat
  • Text

• Know Your Monoclonal Antibodies

  https://modernod.com/topics/nutritionpharmaceuticals/know-your-monoclonal-antibodies/38531/
  These pharmaceutical agents are used to treat a variety of ocular diseases. Knowing how they’re dosed and their potential side effects will serve you and your patients well.
  • Text

• Bacterial Conjunctivitis or Something Else?

  https://modernod.com/topics/ocular-surface/bacterial-conjunctivitis-or-something-else/38516/
  Can you spot the masqueraders? This guide points out distinguishing characteristics to help you make the right diagnosis the first time.
  • Text

• In-Office Treatment Options for MGD

  https://modernod.com/topics/ocular-surface/in-office-treatment-options-for-mgd/38496/
  Familiarize yourself with what’s available in order to manage your patients appropriately.
  • Text

• A Fresh Look at the Endocannabinoid System

  https://modernod.com/topics/glaucoma/a-fresh-look-at-the-endocannabinoid-system/38493/
  Cannabinoids hold promise for the treatment of chronic pain.
  • Text

• Previous
• 1
• 2
• …
• 65
• 66
• 67
• 68
• 69
• …
• 568
• 569
• Next